thalidomide has been researched along with Hyperidrosis in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Deaner, P | 1 |
Deaner, PB | 1 |
Smithells, RW | 1 |
3 other studies available for thalidomide and Hyperidrosis
Article | Year |
---|---|
Thalidomide for distressing night sweats in advanced malignant disease.
Topics: Fever; Humans; Hyperhidrosis; Lung Neoplasms; Male; Mesothelioma; Middle Aged; Thalidomide | 1998 |
The use of thalidomide in the management of severe sweating in patients with advanced malignancy: trial report.
Topics: Adult; Aged; Female; Humans; Hyperhidrosis; Male; Middle Aged; Neoplasms; Quality of Life; Terminal | 2000 |
Thalidomide, absent appendix, and sweating.
Topics: Appendix; Child; Female; Humans; Hyperhidrosis; Thalidomide | 1978 |